Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K
Bone Remodeling01:40

Bone Remodeling

40.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.1K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

9.7K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
9.7K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

7.7K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
7.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sorting Out Vasoreactivity in Pulmonary Arterial Hypertension With SNX29.

Circulation research·2026
Same author

Corrigendum to: Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke.

Current medicinal chemistry·2026
Same author

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
Same author

Precision RNAi for Fibrodysplasia Ossificans Progressiva: a combinatorial, unimolecular, allele selective approach.

Research square·2026
Same author

Growth plate cartilage-targeting nanoparticles for pharmacological treatment of hypochondroplasia.

Bioactive materials·2026
Same author

Comparison of Bone Marrow Stimulation and Particulated Autologous Cartilage Transplantation for Osteochondral Lesions of the Talus With a 2-Year Follow-up.

Orthopaedic journal of sports medicine·2026

Related Experiment Video

Updated: Dec 22, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.1K

A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation.

Jung-Min Kim1, Yeon-Suk Yang1, Kwang Hwan Park2

  • 1Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Nature Communications
|May 10, 2020
PubMed
Summary
This summary is machine-generated.

A CK2/HAUSP pathway regulates RUNX2 stability, crucial for bone formation and preventing heterotopic ossification. This pathway controls skeletal stem cell differentiation and offers therapeutic targets for mineralization disorders.

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.9K
Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
07:26

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis

Published on: April 1, 2022

2.3K

Related Experiment Videos

Last Updated: Dec 22, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.1K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.9K
Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
07:26

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis

Published on: April 1, 2022

2.3K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Skeletal Biology

Background:

  • Osteoblast differentiation of skeletal stem cells (SSCs) requires tight regulation to prevent low bone mass and heterotopic ossification (HO).
  • RUNX2 is a key transcription factor for osteogenesis, but its posttranslational modifications are not fully understood.
  • Dysregulation of bone formation leads to skeletal fragility and ectopic bone development.

Purpose of the Study:

  • To elucidate the mechanisms controlling RUNX2 stability and its role in osteoblast differentiation and HO.
  • To identify key proteins involved in the posttranslational regulation of RUNX2.
  • To explore the therapeutic potential of targeting RUNX2 regulation.

Main Methods:

  • Investigated the interaction between Casein kinase 2 (CK2), herpesvirus-associated ubiquitin-specific protease (HAUSP), and RUNX2.
  • Utilized biochemical assays to assess RUNX2 phosphorylation, ubiquitination, and degradation.
  • Examined the role of the CK2/HAUSP pathway in SSC commitment, osteoprogenitor maturation, and HO models.

Main Results:

  • Identified a novel CK2/HAUSP pathway that stabilizes RUNX2.
  • CK2 phosphorylates RUNX2, recruiting HAUSP to prevent its proteasomal degradation.
  • This pathway is essential for SSC differentiation into osteoprogenitors and subsequent bone formation.
  • Inhibition of the CK2/HAUSP/RUNX2 pathway effectively blocked HO in multiple experimental models.

Conclusions:

  • Active deubiquitination of RUNX2 by the CK2/HAUSP pathway is critical for proper bone formation.
  • This pathway plays a vital role in regulating skeletal stem cell fate.
  • Targeting the CK2/HAUSP deubiquitination pathway presents a promising therapeutic strategy for disorders involving abnormal mineralization.